To expand our investigations towards SMOi-resistant cancer cells, we turned to Ewing sarcoma (EWS) cells, where SMO-independent GLI1 expression is driven by the EWS–FLI1 fusion oncogene [54] (Figure 2A). The gene discussed is FLI1; the disease is Ewing sarcoma.